ArticleCancer pathogenesis and therapy2026

Safety and efficacy of JWATM204, a novel Glypican-3 (GPC3)-targeted CAR T cell therapy for advanced hepatocellular carcinoma: A phase I dose-escalation study.

Yongqiang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.